Phase I Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel + CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Agatolimod (Primary) ; Malaria vaccine (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions
- 06 Nov 2008 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.
- 26 Jan 2007 New trial record.